Aoti Campus Pediatrics and Pediatric Endocrinology Ward

The Pediatric Endocrine, Genetic and Metabolic Diseases Specialty of Shandong Provincial Hospital was founded in April 2011. It reports development under former director Li Guimei and current leader Sun Yan, and describes its clinical and research level as leading in Shandong and advanced nationally. The specialty holds deputy leadership in the Chinese Medical Doctor Association pediatric genetics group, membership in the Chinese Medical Association pediatric endocrine–genetic–metabolic group, and chair positions in Shandong groups for pediatric endocrinology, adolescent health and pediatric endocrine–genetic–metabolic diseases. It is a member of the first national child growth education demonstration bases and child growth quality-control center. It lists a World Diabetes Foundation–China childhood diabetes management project center in 2013, public education base for precocious puberty in 2017, hospital top-ten brand department in 2018, national pediatric endocrine drug trial site in 2019 and Shandong representative training base for child growth capacity under the National Health Commission's continuing education center in 2022. It reports nearly 20 drug trials. Founding director Li Guimei's diagnostic system for pediatric pituitary–target gland hypofunction received the 2017 Shandong science and technology first prize; Sun Yan received the Qilu health leadership talent title. Clinics cover pediatric endocrinology, short stature, genetic and metabolic disease, obesity, rare disease and fertility preservation. The team treats pediatric and adolescent diabetes, pituitary hypofunction, short stature, obesity, precocious puberty, thyroid and adrenal disease, diabetes insipidus, differences in sex development, bone metabolism abnormalities and genetic or rare diseases. It reports early national use of closed-loop insulin pumps in children, a provincial pediatric diabetes data platform, use of the 722 pump and real-time continuous glucose monitoring for type 1 diabetes, care for over 1,500 children with diabetes and diagnosis of inherited childhood diabetes. As a member of the provincial rare disease diagnosis and quality-control centers, it reports disease reporting, treatment and education; enzyme replacement for mucopolysaccharidoses, precision care for hypophosphatemic rickets and neurofibromatosis type 1, and experience in methylmalonic acidemia and congenital adrenal hyperplasia. It leads a provincial pediatric endocrine alliance of 55 member institutions, provides specialist training and hosts an annual national course on advances in pediatric endocrine, genetic and metabolic diseases.